Published on : Jul 29, 2016
Though a number of doctors have raised their concerns on the need for improvement, still a number of surgical robots are predicted to hold a dominant place in operating rooms globally. In the next five years, it is expected that one in every surgery that takes place in the U.S is anticipated to be carried on by robotic systems, having surgeons sitting and guiding the mechanical arms. A number of companies operating in the robots market have also expanded their utilization of these robots in China, India, and other developing markets.
The manufacturers of the next wave are aiming to manufacture less expensive and more nimble robots, which are capable of undertaking more varieties of procedures. Though surgical robots have been running on an average of about US$1.5 mn and comprise the continuing maintenance expenses, still the insurers do not pay more for the surgeries that have been utilizing the systems for other kind of minimally invasive surgeries including laparoscopy, etc.
Inspite of these facts, a number of top U.S. hospitals involved in the treatment of cancer, gastroenterology, urology, and gynecology have invested in surgical robots. These kind of robots are also featured extensively within hospital marketing campaigns and are aimed at luring patients, having new doctors daily trained for using them.
A number of doctors exclaimed that these robots will be outperforming laparoscopic surgeries. Surgeons also exclaimed that they would want these robots to present a way for feeling the tissues of the body remotely, known as haptic sensing, and also featuring enhanced image quality in cameras.
The device maker, named Medtronic stated that they are likely to introduce their surgical robot prior to mid-2018 and will first start from India. The other companies making surgical robots are Canada’s Titan Medical Inc. and TransEnterix Inc. These introductions of surgical robots may bring a revolution in the medical world with more successful surgeries taking place at economical prices.